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ABSTRACT
Objective To investigate whether PALSA PLUS, an on-site
educational outreach programme of non-didactic, case
based,iterativeclinicaleducationofstaff,ledbyatrainer,
canincreaseaccesstoandcomprehensivenessofcarefor
patients with HIV/AIDS.
Design Cluster randomised trial.
SettingPublicprimarycareclinicsofferingHIV/AIDScare,
antiretroviral treatment (ART), tuberculosis care, and
ambulatory primary care in Free State province, South
Africa.
Participants Fifteen clinics all implementing
decentralisation and task shifting were randomised. The
clinics cared for 400000 general primary care patients
and 10136 patients in an HIV/AIDS/ART programme.
There were 150 nurses.
Intervention On-site outreach education in eight clinics;
no such education in seven (control).
Main outcome measures Provision of co-trimoxazole
prophylaxisamongpatients referredto the HIV/AIDS/ART
programme, and detection of cases of tuberculosis
among those in the programme. Proportion of patients in
the programme enrolled through general primary care
consultations.
Results Patients referred to the HIV/AIDS programme
through general primary care at intervention clinics were
more likely than those at control clinics to receive co-
trimoxazole prophylaxis (41%, (2253/5523) v 32%
(1340/4210); odds ratio 1.95, 95% confidence interval
1.11 to 3.40), and tuberculosis was more likely to be
diagnosed among patients with HIV/AIDS/ART (7% (417/
5793)v6%(245/4343);1.25,1.01to1.55).Enrolmentin
the HIV/AIDS and ART programme through HIV testing in
generalprimarycarewasnotsignificantlyincreased(53%
v 50%; 1.19, 0.51 to 2.77). Secondary outcomes were
similar, except for weight gain, which was higher in the
intervention group (2.3 kg v 1.9 kg, P<0.001).
ConclusionThoughoutreacheducationisaneffectiveand
feasible strategy for improving comprehensiveness of
care and wellbeing of patients with HIV/AIDS, there is no
evidencethatitincreasesaccesstotheARTprogramme.It
is now being widely implemented in South Africa.
Trial registration Current Controlled Trials ISRCTN
24820584.
INTRODUCTION
As the price and funding of antiretroviral drugs
become less of a barrier to provision of antiretroviral
treatment (ART) in low and middle income countries
1
attention has turned to the challenges that remain
23:
shifting tasks from doctors to nurses to mitigate the
worst shortages in human resources,
4 decentralisation
from hospitals to peripheral clinics to broaden geogra-
phical access to ART and equity,
5 and integration of
HIV/AIDS and ART care with tuberculosis care and
otherprimarycaretostrengthenqualityandefficiency
ofcaredelivery.
6Taskshiftinganddecentralisationare
beingimplementedinpilot
7andnational
8HIV/AIDS/
ARTprogrammesfundedbyAfricancountriesandby
the US Presidential Emergency Program for Aids
Relief (PEPFAR)
9 and the Global Fund to Fight
AIDS, Tuberculosis, and Malaria,
10 showing large
improvements in coverage and in increased volume
of patients served.
There is less experience with integration as few
health systems in low or middle income countries
have tried to integrate HIV/AIDS/ART care. Instead
a “vertically” organised delivery system is established,
separately managed, staffed, and supplied from other
primary care services in the same facilities. These ver-
tical programmes contradict global recommendations
favouring integration of HIV/AIDS and ART care
with tuberculosis
1112 and primary care.
13 Vertical
approaches are thought to result in poor quality of
care
14 because clinicians not trained in HIV care
might manage patients for their presenting problem,
missing an underlying HIV infection or complication,
while clinicians trained in HIV/AIDS care might miss
or mistreat tuberculosis
15 among their patients. Verti-
cal organisation of service delivery requires that
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HIV,whichisinefficient forthehealthcaresystemand
difficultfor patients,potentially raisingcosts and redu-
cingthequalityandcohesivenessoftheircareaswellas
their long term adherence and follow-up. Vertical
organisation could weaken health systems
16 as scarce
professionals might move to better paid jobs in exter-
nallysupportedverticalHIVcareprogrammes,which
do not share the new resources for HIV/AIDS care
with other parts of the health system. Concerns have
been raised regarding the quality and sustainability of
vertical ART programmes.
17 Integration is presumed
to improve
1819 HIV/AIDS/ART outcomes, but this is
supportedbyonlytwocasestudies,whichdidnotcom-
pare outcomes or processes of integrated care with
usual care or an alternative.
2021
Promising free diagnosis, monitoring, and ART for
those with AIDS, the 2003 South African National
OperationalPlan allocatedfunding for240 ART treat-
mentcentresacrossallnineprovinces.
22Thiswastobe
the world’s largest free ART programme
23—a
responsetoanepidemickilling300000SouthAfricans
each year.
24 Eight provinces chose to begin by provid-
ing ART through hospital based physicians, delaying
task shifting and decentralisation, but one, the Free
State province, chose to begin by decentralising all
ART care after the initial prescription of ART to exist-
ing communitybased primarycareclinics,and to deli-
ver that ART care largely through task shifting to
nurses.
25 As full structural integration of HIV/AIDS
and ART care with other healthcare delivery might
require substantial reorganisation of clinic processes
and staff, entailing risk to all primary care delivery,
thisprovincealsosimultaneouslytestedalowriskstrat-
egy for promoting integration of HIV/AIDS/ART
care with general primary care and tuberculosis care,
usingoutreacheducationtointegratetheseteamsfunc-
tionally, rather than structurally.
26
We evaluated the incremental impact of educational
outreach on healthcare quality and health status out-
comes among patients with HIV/AIDS receiving
ART. Educational outreach was delivered as a clinic
based, on-site adult education programme of non-
didactic, case based, iterative clinical education of all
stafftogether,includingstaffprovidinggeneralprimary
care, tuberculosis care, and HIV/AIDS/ART care, led
by an outreach trainer (fig 1). This aimed to achieve
sharing of knowledge and integration of care among
staff in primary care clinics. We evaluated this added
intervention in a cluster randomised trial, in which
clinics and their staff in both arms also received the
usual approach to task shifting and decentralisation.
METHODS
Study design
Weconducteda pragmatic
27clusterrandomisedtrial
28
oftheeffectsofaddingoutreacheducationtoa roll-out
of decentralised nurse run HIV/AIDS/ART services
at primary care clinics.
Randomisation
The unit of randomisation was the clinic, stratified by
health district. Urn randomisation (chosen for simpli-
city, given the small number of units) was done with
folded slips of paper marked with clinic names,
selectedblindlyfromacontainerbythetrialstatistician
before the intervention or recruitment of patients.
29
Outcome data were collected on individual patients.
Allocation was conducted centrally at the same time
as randomisation and thus concealed. No blinding
waspossiblebecauseoftheobviousnatureoftheinter-
vention. Each stratum (district) contained three ART
clinics and a single hospital, to which those clinics
referred patients for physician care (fig 2). Three ran-
domly selected districts were randomised at a ratio of
two intervention clinics to one control clinic, leaving
twodistrictswitharatioofoneinterventiontotwocon-
trol clinics (total eight intervention and seven control
clinics).
Setting and programme
Usual care
The Free State HIV/AIDS/ART care programme
(other than initial ART prescription and care of com-
plications, which were to be provided by physicians)
was being decentralised to nurse clinicians at each of
the 15 community basedgeneral primarycare (includ-
ing tuberculosis care) clinics accredited as having the
facilities, such as private consultation space, for ART
care.
One or two experienced, fully qualified nurse clini-
cians from each of the 15 clinics were selected to
receive a five day lecture based training course on
ART, delivered by health department experts, mainly
physicians, at a central venue. All ART specialist
nurses also received a copy of the current guideline
formanagementofHIV,includingphysicianinitiated,
nurse maintained ART, and adult respiratory diseases
including tuberculosis. The guideline was evidence
based, and adhered to national HIV/AIDS clinical
recommendations and to provincial prescribing rules
and referral criteria applying to nurses. Once trained,
these newly appointed ART nurse specialists were to
see HIV/AIDS/ART patients, referring HIV patients
tohospitalbasedphysiciansforinitiationofARTwhen
the CD4 count fell below 200 cells/μl. They were also
toprovideongoingguidelinebasedcareforpatientsin
whom ART was initiated, issuing monthly repeat pre-
scriptions, and conducting laboratory and clinical
monitoring for side effects and complications, with
referral back to hospital physicians as needed. Every
six months nurses were also responsible for taking
blood samples for measurement of CD4 counts and
viral loads the month before the patient returned to
the doctor for their scheduled six monthly repeat pre-
scription, so that the results were available for the doc-
tor to review at the time of renewing the prescription.
They were also expected to support the general pri-
mary care team (who provide HIV counselling and
testing to general patients).
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lished in the same small building as the tuberculosis
and general primary care clinics but in different con-
sultation rooms. The general primary care clinic is the
plannedentrypointfornewpatientstotheHIV/AIDS
programme,andtheplannedsiteofprescriptionofco-
trimoxazole for patients with a new diagnosis of HIV
before their referral to the specialist run HIV/AIDS/
ARTprogramme.Thustheplannedmodelofcare(the
usual care provided by the control group clinics in the
trial reported here) could be defined as decentralisa-
tion of ART with task shifting, but not integration, as
tasks for HIV/AIDS/ART care and tuberculosis care
were to remain divided between specialists and gener-
alists in the same clinic building, the former focusing
on clinical care of people already identified as HIV
positive and people with AIDS defining conditions or
CD4 counts already receiving ART, including the
tuberculosis care of such patients. General patients,
patients with tuberculosis, and patients seeking or
needing HIV screening were looked after by general
or tuberculosis staff until an HIV diagnosis and then
referredontothespecialistnursesinthesamebuilding.
Intervention
The intervention was additive to the usual care
described above and delivered only in the eight inter-
ventionclinics.Itwasbasedoneducationaloutreach
30:
awellprovedandmodestlybutvariablyeffectivestrat-
egy for change in professional practice, consisting of
short, face to face, interactive education of clinicians
at the workplace by a trusted non-commercial educa-
tor. The intervention aimed to produce cognitive,
rather than physical or organisational, integration—
thatis,toenablespecialistARTnursestothinkbeyond
HIV aspects of the care of their patients, and tubercu-
losis and general nurses to think of caring for HIV
aspects of their patients’ care, irrespective of present-
ing complaints. In consultation with their managers
and the individuals themselves, the research team
selected 10 nurse managers, already employed by the
Free State, as outreach educators for the intervention
clinics. They received no payment from the research
team, gained no extra benefits from their employer,
and were drawn equally from the provincial HIV and
tuberculosis programmes. All attended a five day
workshop led by members of the research team on
educational outreach techniques and on the clinical
content of the guidelines.
3132 To maintain the compe-
tence of the outreach educators the research team also
provided three one day follow-up workshops—not at
primary care clinics—over a six month period.
Over this period the outreach educators were asked
to deliver at least eight outreach sessions of one to two
hoursateachinterventionclinictoagroupofallnurses
(including the ART specialists), lay counsellors, com-
munity health workers, and administrative staff avail-
able at each clinic on outreach visit days. All
professional staff at the intervention clinics received a
copy of the integrated syndromic guideline. Visits
were repeated until the educators were satisfied that
all staff were familiar with the diagnosis, treatment,
and complications of HIV/AIDS, tuberculosis, and
other conditions covered in the guideline described
above, at a level appropriate to their responsibilities
in the clinic. Four outreach educators supported one
intervention clinic each; six worked in pairs, each
pair supporting one or two clinics.
Clinics
We enrolled all three clinic based ART sites in each of
the five administrative districts of the Free State Pro-
vince. These 15 were the first wave of ambulatory
clinics to provide decentralised HIV/AIDS/ART
care in the province. No sampling was used. Clinics
were staffed by a median of 10 nurses, one to three of
whom were newly trained to run the separately orga-
nised ART service in the same building (table 1).
Patients
Allpatientsaged16orolderenrollingintheART pro-
gramme through any channel (including voluntary
counselling and testing) at any of the 15 clinics during
oneyearwereincludedinthetrialandmonitoreduntil
death or completion of the trial. In every clinic in each
district (stratum), the study began the first month after
the specialised HIV/AIDS/ART nurses had been
trained and deployed in intervention and control
clinicsandthelocaloutreacheducatorshadcompleted
Usual care
(ART specialist training)
Intervention group
(addition of PALSA PLUS outreach training)
Centralised training of district staff – removes 
staff from the context of their own clinic, limits 
discussion of clinic specific logistic issues at 
training sessions. Intense burst training, 
leaving little time for consolidation of new 
learning and integration with experience
Attendance by ART nurses only, from multiple 
clinics – creates specialisation, disease 
specific professional identification, lifts nurses 
away from the context of the clinics in which 
they will work, reduces their identification with 
clinic team, and promotes disease specific 
separation of work in clinic
ART doctors and nurses are trained together, 
encouraging vertical disease specific 
understanding, the formation of vertically 
organised clinic nurse to hospital doctor ART 
team, structures with emphasis on referral. 
Disease specific, medically dominated view of 
ART. Encourages knowledge hierarchy
Lecture format: expert presentations (primarily 
didactic and unidirectional) by multiple 
specialists. Little room for testing own ideas 
and understandings; challenging environment 
for asking questions. Disease oriented training 
approach
Predominantly ART specific HIV care, 
encourages silo approach to HIV
Multiple materials covering presentations, 
including PALSA PLUS guideline. There might 
be multiple versions of same technical points. 
Variable quality of material design
Decentralised (onsite at individual clinics) 
– contextualises training within each clinic and 
its own logistical patterns; encourages team 
functioning, playing to strengths of individuals 
and ensuring better coordination between ART 
nurses and other nursing staff. Multiple 
sessions allow intervening time for integration 
of learning with practice
Attendance by all nurses in each intervention 
clinic – integrates all nurses into the clinic HIV 
care team, encourages ART nurses to take 
other healthcare needs besides ART into 
account in scheduling visits and planning 
treatment
Training designed specifically for nurses, 
increases likelihood that clinical content takes 
nurses’ skills and concerns into account; 
weights treatment at clinic more equally with 
referral out of clinic; allows local understand-
ings of clinic/community relations to be 
integrated into discussions
Educational outreach (facilitative, interactive) 
by trained group facilitators. Explicit attention 
paid to group process, uncertainty and 
complexity of issues and materials acknowl-
edged and so increased openness to 
admissions of difficulties and problems
Lung health, tuberculosis, HIV, and ART care, 
explicitly integrates understanding and care 
of multiple diseases
PALSA PLUS guideline (and support materials) 
only. Single, fully reconciled, and coordinated 
set of teaching, learning, and retained 
materials; carefully designed with adult 
education principles in mind
Fig 1 | Comparison of ART specialist training and PALSA PLUS outreach approach
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port to the intervention clinics. Districts began data
collection for the study between 1 July 2004 and 30
November 2005, and patients were recruited and fol-
lowed up in all facilities in each district for 12 months
after data collection began.
Data collection
Each time a patient with HIV visited the clinic (or hos-
pital),anurse(ordoctor)recordedclinicalinformation
on paper forms. Trained data capturers then entered
the data on the province’s computerised HIV record
systembytraineddatacapturersanduploadedthemto
a central database. Entries were checked with auto-
matedqualitycontrolroutines,withrecordswithmiss-
ing or contradictory information returned for
correction. Deaths were identified by electronically
linking patients’ data with the national death register
by using national identity numbers.
33 Diagnoses of
tuberculosis, made according to national guidelines,
34
were obtained from the HIV records or through link-
age with the tuberculosis treatment register.
Outcome measures
Because the intervention is complex, it could have
independent effects on several different aspects of
care, and as such the effect of the intervention needs
tobequantifiedbya“family”ofthreeseparateprimary
outcome measures: firstly, integration of HIV/AIDS
andARTcarewithtuberculosiscare;secondly,overall
quality of pre-ART care provided at the clinic for
patientswhoareHIVpositive;and,thirdly,integration
of general primary care provided by nurses with HIV
screening. The first primary outcome, detection of
tuberculosis among patients with HIV, reflects the
quality of awareness of tuberculosis and care among
the HIV/AIDS/ART programme specialists; the
second, co-trimoxazole prophylaxis among patients
with a new diagnosis of HIV, reflects the quality of
pre-physician clinic care for HIV positive patients,
which is provided mainly by general primary care
nurses immediately after they diagnose HIV in their
general clinics, and also by specialist nurses after the
general nurse refers the patients with a new diagnosis
into the HIV/AIDS and ART programme. The third
outcome, the proportion of patients enrolled in the
ART programme through newly conducted HIV test-
ing,reflectstheindexofsuspicionforHIVamonggen-
eral nurses treating a full range of presenting
complaints in primary care patients.
Other outcomes were precautionary as we had no
reason to expect that ART or its outcomes (viral load
suppression, mortality, weight gain) would differ
between arms; ART was initiated by physicians and
monitored in both arms by similar specialist ART
nurses. We also included a further marker of the qual-
ity of pre-ART care (CD4 follow-up in those not eligi-
ble for ART at first presentation) and counted clinic
visits to track use of healthcare.
Sample size and statistical power
As we included all eligible patients in all proposed
ART clinics there was no sampling. We carried out a
power calculation, rather than an estimation of neces-
sarysamplesize.Decisionmakersexpectedthatthe15
clinics would have a mean of 500 patients in the HIV/
AIDS/ART programme and were looking for an
improvement of 20% or more in any one of the three
primaryoutcomes.Outcomes ofourpreviousstudyof
outreach education in the province had intracluster
correlation coefficients between 0.019 and 0.007,
25
meaning that, with an α of 0.05, our proposed trial
had over 80% power to detect the desired improve-
ment in the primary outcomes.
35
Statistical analysis
Descriptive statistics were pooled over the five dis-
tricts, unweighted. We use four regression models to
estimate effects, with district as the covariate for strati-
fication: logistic regression for binary outcomes (such
as co-trimoxazole prescribing), linear regression for
continuous outcomes (such as weight gain), Cox pro-
portional hazards for time-to-event outcome (such as
mortality), and Poisson regression for count outcomes
(such as clinic attendances). The model parameters
wereestimatedbythegeneralisedestimatingequations
approach, which takes into account clustering of out-
comes within clinics. We estimated treatment effects
(oddsratios,differenceinmeans,hazardratio,andinci-
dence rate ratio) with 95% confidence intervals. All
outcomes were analysed on an intention to treat
basis, except for mortality, for which we excluded
fromtheanalysispatientswithonlyonerecordedvisit.
Consent
Enrolmentofclinics inthe trialwasat the behestofthe
Free State Department of Health. Individual patients
Clinics randomised to control (n=7) Clinics randomised to intervention (n=8)
Enrolled (n=5793)
HIV positive (n=5523)
HIV negative (n=270)
Median clinic cohort size (n=724, range 139-1357)
Enrolled (n=4343)
HIV positive (n=4210)
HIV negative (n=133)
Median clinic cohort size (n=655, range 131-1626)
First 15 primary care clinics to implement public sector programme in Free State province, South Africa
Clinical selection
Randomisation completed within five health districts according to random allocated ratio
ThaboMofutsanyana (2:1), Lejweleputswa (1:2), Fezile Dabi (2:1), Motheo (2:1), Xhariep (1:2)
Allocation
Enrolment
Clinics (n=8/8)
Patients:
Median follow-up period 23 (IQR 7-41) weeks
No with 1 visit (n=1039/5793)
No with  ≥2 visits (n=4754/5793)
Of these (n=4754), 958 (20.1%) died
Clinics (n=7/7)
Patients:
Median follow-up period 28 (IQR 9-45) weeks
No with 1 visit (n=698/4343)
No with  ≥2 visits (n=3645/4343)
Of these (n=3645), 792 (21.7%) died
Follow-up
Fig 2 | Details of clinic selection, allocation, enrolment, and follow-up in trial (IQR=interquartile
range)
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the same access to ART medications, guidelines, phy-
sicians and designated, trained ART nurses. All data
were obtained from computerised routine clinical
records or other existing administrative and demo-
graphic databases.
RESULTS
Characteristics of clinics and patients—Characteristics of
patients and clinics were comparable at baseline
(table 1). All clinics completed the trial (fig 2). The
eight intervention clinics enrolled a median of 724
patients per clinic, with a median follow-up of
23 weeks (interquartile range 7-41 weeks) to the end
of the study or loss to follow-up; the seven control
clinics enrolled 655 patients per clinic, with a median
follow-up of 28 weeks (9-45 weeks). Intervention
clinics had more patients and more staff (table 1).
The median CD4 count at enrolment was slightly
lower in the intervention group, though control
patients were slightly more likely to have advanced
clinical infection.
Intervention—Trainers delivered a median of 14.5
(range 6-20) educational outreach sessions to each
intervention clinic. Clinic nurses attended a median
of five (range 0-14) sessions each.
Outcomes—The intervention was effective for two of
thethreeprespecifiedprimaryoutcomes(table 2).Co-
trimoxazole prophylaxis was more likely to be pre-
scribed (1.95, 95% confidence interval 1.11 to 3.40)
and tuberculosis was more likely to be diagnosed
(1.25, 1.01 to 1.55) among patients attending inter-
vention group clinics, but there was no evidence that
theinterventionwaseffectiveinincreasingrecruitment
into the HIV/AIDS/ART programme from primary
care (1.19, 0.51 to 2.77).
Other outcomes—Viral load, mortality, use of health-
care, and monitoring of CD4 counts were similar in
botharms,whileweightgainfavouredtheintervention
group (mean difference 0.55 kg, 0.30 to 0.79 kg;
P<0.001; table 2).
DISCUSSION
Educational outreach to promote shared knowledge
and awareness of all staff on HIV/AIDS/ART, tuber-
culosis, and general primary care substantially
increasedprescriptionofco-trimoxazoleanddiagnosis
of tuberculosis and initiation of tuberculosis care
among patients with HIV/AIDS. There was no evi-
dence that it increased the probability of patients in
general primary care being screened and referred for
HIV/AIDS/ART care. The increase in diagnosis of
tuberculosis is appropriate as all were microbiologi-
cally confirmed or, if a sputum smear yielded negative
results,diagnosedbyaphysician.Theincreasedco-tri-
moxazole prescribing, which concentrated on patients
withaCD4count<200/cells/μl,alsoadherestoguide-
lines (see table 2). Weight gain also improved slightly,
a clinical sign of improved care. These successes are
important as they increase survival
36 and reduce the
transmission of tuberculosis.
37
Policy implications
PALSAPLUS combinedoutreach education,simplifi-
cation of treatment,
3839 and supportive supervision,
40
resultinginimportantimprovementsincareunderrea-
listic conditions, within local constraints on human
resources and organisations. It is an effective addition
to decentralisation and task shifting, which is worth
implementing in nurse led services in South Africa,
even in the absence of structural integration of HIV/
AIDS/ARTandgeneralprimaryandtuberculosiscare
(and possibly as an initial step towards it).
Eventhoughitincreasedtheprobabilitythatgeneral
primary care and tuberculosis clinicians would pre-
scribe co-trimoxazole prophylaxis, the intervention
did not increase the likelihood that these same clini-
cians would screen for HIV and refer. We explored
this in a post hoc analysis (see table 2), which showed
alargeandsignificantincrease(interventionrelativeto
control group) in the proportion of the general clinic
attendees who the general nurses screened for HIV
and referred to the HIV/AIDS/ART programme in
the first month of the trial, but this initial intervention
advantageequalisedbetweenarmsovertheyearoffol-
low-up. Our qualitative study alongside this rando-
mised controlled trial suggests that this lack of
Table 1 |Characteristics of clinics and patients according to additional outreach intervention
or usual care in decentralising HIV/AIDS/ART programme. Figures are numbers (percentages)
unless stated otherwise
Outreach group Control group
Clinics
No of clinics 8 7
Median quarterly adult attendances 8929 7236
Median No of nurses per clinic 11 9
Median distance from referral site (km) 25 25
Patients with HIV
No of patients 5523 4210
Sex (women) 3576/5521 (65) 2764 (66)
Mean age (years) 35.4 35.6
Any previous antiretroviral treatment 59 (1) 39 (1)
CD4 count at enrolment (cells/μl):
Median (IQR) 166 (71-319) 185 (84-339)
<25 388 (7) 278 (7)
25-49 344 (6) 219 (5)
50-99 615 (11) 427 (10)
100-199 1064 (19) 758 (18)
200-349 798 (14) 725 (17)
≥350 892 (16) 749 (18)
Unknown 1422 (26) 1054 (25)
Mean weight at enrolment (kg) 56.7 57.0
WHO stage at doctor assessment:
Stage 1/2 761/1815 (42) 435/1359 (32)
Stage 3/4 1057/1815 (58) 924/1359 (68)
Employed 127/1014 (13) 102/1044 (10)
Median (IQR) household size 4 (3-6) 4 (3-6)
Household receiving social welfare 445/1006 (44) 500/1027 (49)
IQR=interquartile range.
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counselling that non-HIV specialist staff must provide
to patients to encourage their consent for screening.
Staff find this counselling emotionally draining, and it
requires skills that were not provided by the inter-
vention training.
41 We have since adapted the training
to provide more of this kind of skill and support.
Strengths and weaknesses of the study
Studyarmswerebalancedatbaseline,andtherewasno
loss of clusters to follow-up. Cluster randomisation
permitted uncontaminated estimation of the effects of
acomplexintervention,whileuseofthreeprimaryout-
comes showed the different direction of the effects of
the intervention on separate aspects of care, justifying
ourchoicenottoadjustformultiplecomparisons.Ran-
domisation and implementation of the intervention
proceeded smoothly. The inclusion of all ART clinics
andpatientsinoneofSouthAfrica’spoorerprovinces,
rather than the common reliance on atypically
resourced demonstration sites, supports wider applic-
ability of these results to other constrained healthcare
systems.
Differences in outcomes between arms might have
been reduced by the distribution and widespread use
of our evidence based syndromic guideline in control
sites. This element of the intervention is obviously less
useful without the shared outreach training to use it
correctly but could still have had some benefit; as a
new programme, there are no comparable before and
after data on HIV screening with which to separately
estimate the effect of the guideline. Our reliance on
sources of routinely collected clinical data, with some
missing values, could also slightly blur contrast
between the groups, though our large sample size
counteracts this imprecision. The fact that ART initia-
tion remaineda physician and hospital activity in both
arms might place a ceiling on the impact that could be
obtained by the intervention.
42 These limitations sug-
gest our study might lean towards underestimation of
the potential impact of this approach.
Mortality was high in both arms, in keeping with
previously reported observational cohort data for
these patients, probably because of the large number
oflatestagepatientsinthestart-upARTprogramme.
43
There was a moderately large intracluster correla-
tioncoefficientformostoutcomes,suggestingvariabil-
ity in the effectiveness of the intervention between
clusters. The intervention was permitted to vary in
response to local conditions, through, for example,
adding training sessions as needed.
43 This could have
contributed to variability in outcomes between clus-
ters, though we believe responsiveness to local need
probably had the opposite effect. The overall out-
comes of the study, however, were broadly positive,
supporting a recent review suggesting that adaptation
to local conditions is associated with successful scale-
up.
44
Applicability
There were no signs of disruption in ART care, use of
healthcare remained unchanged, and, despite the
added responsibilities, staff morale improved.
40 We
chose outreach educators from among existing nurse
supervisors and incorporated the new roles into their
existing responsibilities (no extra positions were cre-
ated nor were any replacements hired). There was no
extra financial reward, facilitating sustainability and
widespread implementation. With this reassuring
news for managers, the provincial Department of
Health has incorporated the educational outreach
intervention into the control clinics as a province-
wide roll-out. Each outreach educator now supports
four clinics, with one clinic visit every second week in
the first four months, and one visit per quarter there-
after, which is a sustainable ratio in South Africa.
Table 2 |Trial outcomes in intervention clinics (with added PALSA PLUS outreach education) and control clinics (with specialist ART nurse training only)
No (%, SD, or IQR)
OR, HR,MD,orIRR*(95% CI) P value
Intracluster correlation
coefficient Intervention clinics Control clinics
Primary outcomes
Enrolment in programme through new HIV testing (1 year)† 3048/5793 (53%) 2187/4343 (50%) OR 1.19 (0.51 to 2.77) 0.695 0.108
Provision of co-trimoxazole prophylaxis over 12 months 2253/5523 (41%) 1340/4210 (32%) OR 1.95 (1.11 to 3.40) 0.020 0.034
Tuberculosis case detection† 417/5793 (7%) 245/4343 (6%) OR 1.25 (1.01 to 1.55) 0.038 0.027
Preplanned secondary outcomes
Viral load suppressed after 6 months’ antiretroviral treatment 332/389 (85%) 332/389 (88%) OR 0.96 (0.74 to 1.26) 0.779 0.088
Mortality 958/4754 (20%) 792/3645 (22%) HR 0.90 (0.67 to 1.19) 0.466 NA
CD4 follow-up among patients with initial CD4 200-500 cells/μl 1127/1276 (88%) 954/1141 (84%) OR 1.39 (0.65 to 2.96) 0.40 0.022
Weight gain (kg) 2.3 (SD 5.8) 1.9 (SD 6.1) MD 0.55 (0.30 to 0.79) <0.001 0.10
Clinic visits 6 (IQR 3-15) 8 (IQR 4-19) IRR 0.95 (0.77 to 1.18) 0.658 0.026
Post hoc exploratory analyses of primary outcomes
Enrolment in programme through new HIV testing (1 month) * 357/653 (55%) 214/499 (43%) OR 1.58 (1.01 to 2.48) 0.054 0.113
Provision of co-trimoxazole prophylaxis to patients with ≤200 CD4
cells/μl, AIDS, or tuberculosis
1762/2419 (73%) 1025/1572 (65%) OR 1.88 (1.07 to 3.31) 0.029 0.035
IQR=interquartile range.
*OR=odds ratio; HR=hazard ratio; MD=mean difference; IRR=incidence rate ratio.
†Denominator includes all patients enrolled in treatment programme, as well as patients who were tested through programme with negative results.
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We cannot tell whether the upper limit of tuberculosis
detection has been reached as the prevalence in clinic
populations has not been studied against a standard
diagnostic, but there clearly remains room for further
improvement in co-trimoxazole prophylaxis. We
believe this will come about through increasing the
role of nurses in the initiation of ART rather than
through further increases in efforts by general and
tuberculosis staff, and this element will be evaluated
in our ongoing trial of an expanded intervention that
shifts responsibility for most ART initiation and fol-
low-up to nurses.
45 PALSA PLUS has recently been
implemented as the training and support model for
accelerated implementation of HIV/AIDS/ART care
throughout South Africa, but even though it has been
designed for widespread implementation and applic-
ability, the actual effectiveness of the intervention as
it is adapted or applied elsewhere should be further
monitored. Where the context is different, a full prag-
matictrialisrecommended;oneisnowunderwayofan
adapted version of PALSA PLUS in Malawi.
46
This pragmatic randomised trial provided timely,
trustworthy, real world estimates of effects of a novel
locally developed intervention for strengthening and
integration of health services. In the Free State pro-
vince our rigorous evaluation, unobtrusively inte-
grated alongside early stages of programme
implementation, provided formative information for
improving the programme and supported evidence
based decision making on system-wide implementa-
tion. This is a rare example of synergy between
research and policy for strengthening health systems,
for which there is a growing call.
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